NeuraWorx Medical Technologies

NeuraWorx Medical Technologies

Private
Excelsior, MinnesotaHealthcare & Life Scienceshttp://www.neuraworx.com

Last Round

Seed

Dec 18, 2025

Total Funding Raised

$25,000

Company Overview

NeuraWorx Medical Technologies, Inc. is a neurotechnology therapeutics company developing the Cerebrovascular Pacing System, a wearable neurostimulator intended to enhance the brain's waste clearance for improved brain health and to treat disorders like traumatic brain injury and Alzheimer's dementia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

wearable neurostimulatorbioelectronic medicineneurotechnologyneurotechneurostimulationCNS disordersglymphatic systembrain clearancecerebrovascular pacingnon-invasive wearabletraumatic brain injuryTBIneurodegenerative diseaseAlzheimer's diseaseParkinson's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuraWorx Medical Technologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuraWorx Medical Technologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedDec 18, 2025
SeedAug 27, 2024
AcceleratorJul 12, 2023
DebtMay 31, 2023

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Feasibility studies for wearable neurostimulation platform are in progress.

  • Dec 18, 2025

    Completed a Seed funding round.

NeuraWorx Medical Technologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuraWorx Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuraWorx Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersExcelsior, Minnesota
Year Founded2021
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.